Summary The histological detection of tumour metastases in axillary lymph nodes from cases of breast carcinoma is of major prognostic significance, but may be difficult when metastases are of microscopic size. We have therefore investigated whether immunohistological techniques can increase the accuracy of metastasis detection in axillary lymph nodes. Forty-five cases of breast carcinoma were studied, in all of whom the axillary lymph nodes had been reported as free of metastases. Paraffin sections from these cases were stained by immunoenzymatic techniques, using monoclonal antibodies directed against human milk fat globule membrane antigen ("anti-EMA") and against epithelial intermediate filaments ("anti-keratin"). In 4/12 cases of lobular carcinoma and in 3/33 cases of ductal carcinoma, previously unsuspected micrometastases were revealed by immunohistological staining, representing an overall increase in detection rate of 15% (and of 33% for the lobular carcinoma cases). In addition to this group of 45 histologically "negative" biopsies, 12 samples were studied in which only a proportion of the nodes had been reported as containing tumour. In 5 of these cases immunostaining revealed previously undetected metastases. These findings suggest that immunohistological analysis may have a routine role to play in the staging of breast carcinoma. It is noted that the 15% increase in diagnostic accuracy achieved in the present study is comparable to the proportion of breast carcinoma patients in whom disseminated disease develops despite their axillary lymph nodes being reported as tumour-free at the time of surgery.
It is now widely accepted that involvement of axillary lymph nodes by breast cancer has an important bearing on prognosis (Breast Cancer Study Group, 1978; Elston et al., 1982) and a decision on whether or not to undertake adjuvant chemotherapy frequently hinges on the number of involved nodes (Bonadonna, 1980) . However, use of this criterion presupposes that micrometastases can reliably be detected by conventional histological procedures, e.g.: by examination of haematoxylin/ eosin or mucin stains. A negative report therefore indicates that the histopathologist has been unable to identify any malignant cells, rather than that they are absent.
One potential means of improving observer accuracy in the detection of axillary micrometastases is to use immunocytochemical techniques. It has recently been reported by Redding et al. (1983) (Ghosh et al., 1983) .
We therefore undertook in the present study to assess whether immunocytological examination of Correspondence: K.C. Gatter. Received 13 February 1984; accepted 13 April 1984. axillary lymph nodes would offer any advantage over conventional histopathology in the detection of micrometastases. Gatter et al., 1982 Gatter et al., , 1984 . Antibody KLl has been tested in its laboratory of origin on human tissues and found to stain most human epithelia but not non-epithelial cells or tissues. Immunoperoxidase staining Sections were prepared for staining by dewaxing and washing in TBS. Dewaxed sections were then incubated with monoclonal antibody for 30min in a covered chamber. Sections were washed briefly in TBS and incubated for a further 30 min with peroxidase-conjugated rabbit anti-mouse Ig, diluted 1:50 in TBS to (which normal human serum has been added, at a final concentration of 1: 2, in order to block cross-reactivity against human Ig). After washing in TBS, sections were incubated for a further 30 min with peroxidase-conjugated swine anti-rabbit Ig diluted 1:100 in TBS (containing normal human serum at a final concentration of 1:2).
Sections were then washed in TBS and the peroxidase reaction developed by incubating sections with TBS containing diaminobenzidine (0.6 mg ml-1) and H202 (0.01%) for 5-10min at room temperature. Sections were washed in tap water, counterstained with haematoxylin and mounted for microscopical examination.
Immuno-alkaline phosphatase labelling Some of the sections investigated in this study were analysed by a two-stage indirect immuno-alkaline phosphatase procedure. In this technique the initial stages up to and including incubation with the monoclonal antibody were performed as described above. Sections were then washed and incubated with alkaline phosphatase-conjugated rabbit antimouse Ig, diluted 1:20 in TBS containing 5% normal human serum. After a further wash the alkaline phosphatase reaction was developed using a substrate containing hexazotised new fuchsin and naphthol AS-MX, as described previously (Cordell et al., 1984 Figure 4 In all cases the metastatic deposits which had been recognised on conventional histology were strongly stained by the 3 monoclonal antibodies.
Discussion
This study has shown that in 12/57 cases of breast cancer it was possible to detect axillary lymph node metastatases which had been undetected previously on conventional histological examination (including mucin staining). This represents an increase in diagnostic accuracy of just over 20%. Among 45 cases in which the lymph nodes had been reported previously as being free of tumour, 7 cases could be shown to contain micrometastases in one or more lymph nodes. Since 4 of these micrometastases were detected amongst the 12 cases (33%) of lobular carcinoma, with only 3 cases being seen in the 33 (9%) ductal carcinomas, the former group may be the most profitable to examine in a larger study.
In the remaining 12 cases metastatic deposits had already been identified on routine histological examination of a proportion of the lymph nodes received. However immunohistological labelling enabled additional involved nodes to be identified in five cases: this is of potential clinical significance in the context of chemotherapy trials in which treatment is dependent upon the number of involved lymph nodes (Bonadonna, 1980) .
The results in this paper should be compared with those previously reported by Sloane et al. (1980) in which lymph nodes from cases of breast cancer were examined immunohistologically using a polyclonal antiserum directed against epithelial membrane antigen (similar in its specificity to the two monoclonal anti-milk fat globule membrane antigen antibodies used in the present study). However Sloane et al. (1980) (Huvos et al., 1971; Attiyeh et al., 1977; Fisher et al., 1978) . However a recent study from the Sloan-Kettering Cancer Center, New York, of patients with a single lymph node metastasis (Rosen et al., 1981) has shown that, although micrometastases are of no clinical significance six years after surgery, the survival of these patients is nearly identical to that of patients with macrometastases when results are analysed after twelve years.
Of further relevance to the present report is the fact that approximately 20% of breast cancer patients in the Sloan-Kettering series, in whom axillary lymph nodes had been reported as free from tumour, subsequently developed clinical evidence of metastases. This figure is comparable to the percentage of patients in the present series (7/45-15%) in whom micrometastases were detected by immunohistological labelling. The recent report (Redding et al., 1983) 
